
Top Stories 
Published On January 15, 2011
POLICY
Defined: Biocreep
Trials that involve new drugs being compared to existing versions could let inferior treatments slip through.
biocreep: a possible phenomenon in which so-called noninferiority trials, which compare the efficacy of new drugs with that of existing drugs, in fact allow inferior treatments to go to market.
Noninferiority trials, used predominantly in cases in which testing a new drug against a placebo would be unethical, were used in a quarter of new drug tests submitted to the Food and Drug Administration for review from 2002 to 2009. These trials are designed to determine whether the difference between the latest drug and the existing one, dubbed an active control, is “small enough to allow the known effectiveness of the active control to support the conclusion that the new test drug is also effective,” according to the FDA. Yet the U.S. Government Accountability Office recently found cause to investigate the FDA’s definition of “small,” since some noninferiority margins allowed for as much as a 20% lower effectiveness rate compared with the active control. Though no evidence of biocreep was found, the FDA is tightening regulations to prevent the approval of drugs that are no more effective than a placebo.
Dispatches

What Makes a Kid Clumsy? More research into coordination disorders shows why some children are more prone to trip, fumble and spill the milk.

Eyes in the Sky Satellite data can be used to assess the health impact of dust storms and the spread of mosquito-borne diseases. Additional applications could be on the horizon.

Could This One Change Help Curb the Opioid Crisis? To prescribe an effective bridge to addiction treatment, emergency physicians must get special training and receive a waiver. Making that process easier—or eliminating the requirement altogether—could make a big impact.

One Thing Leads to the Next Robert Lefkowitz is best known for revealing the mechanism behind hundreds of drugs in use today. But he thinks of himself as a storyteller first and has a new book out to make his case.

Podcast: The Research Year That Was Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.

The Shape of Us Two milestone discoveries in protein modeling promise to change the fundamentals of drug discovery.

Universal Flu Vaccines Move Forward In the shadow of coronavirus vaccine development, another vaccine was making solid progress.

Top Stories 

The Neuroscience of Giving Up
Why do some people react poorly, even catastrophically, in emergency situations?